Please login to the form below

Not currently logged in
Email:
Password:

Ferring Pharmaceuticals promotes Aaron Graff

He takes up role as chief commercial officer and joins its executive board

Aaron GraffSwiss biopharmaceutical company Ferring Pharmaceuticals has promoted Aaron Graff to chief commercial officer and executive vice president.

He was previously CEO of Ferring’s US operations and in his new role he will also sit on the Saint-Prex-based firm’s executive board.

Graff first joined Ferring in 2002 as VP of global marketing, business development and medical affairs, based in Copenhagen.

After leading the acquisition and integration of Israeli biopharmaceutical company BTG in 2005, he relocated his team to the newly established Ferring International Center in Saint-Prex.

He was then made senior VP, Asia region and global marketing, and since 2010 has led Ferring’s stateside operations from its US headquarters in New Jersey, first as chief operating officer and since 2016 as CEO.

Michel Pettigrew, president of Ferring Pharmaceuticals’ executive board and chief operating officer, said: “Under Aaron’s leadership in the United States, our US business grew at double-digit rates. His broad, global professional experience and track record make him uniquely qualified for this important role.”

Prior to joining Ferring, Graff worked at Bristol-Myers Squibb for over 17 years in a variety of sales, marketing and commercial operations management positions.

2nd June 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics